Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AD.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.201NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JD.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDTNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.617.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.109 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.8 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.617.1 (Kappa)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.16 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.80 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.8 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.128 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used